Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CROVALIMAB-AKKZ: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

43.7%
Female
56.3%
Male

Age Information

The average age of patients reporting adverse events with CROVALIMAB-AKKZ is 69.0 years.

Geographic Distribution

The majority of adverse event reports for CROVALIMAB-AKKZ originate from JP.

Report Summary & Outcomes

38
Total Reports
38
As Primary/Secondary Suspect
4
Deaths Reported
24
Hospitalizations
1
Life-Threatening

Reporting Timeline

First adverse event report: 20240101. Most recent report: 20250908. View full timeline →

More About CROVALIMAB-AKKZ

CROVALIMAB-AKKZ Full Profile Reports by Year Drug Interactions